Preclinical basis for the efficacy of memantine in Alzheimer's disease

被引：0
|
作者：
Banerjee, P. K.
Lahiri, D. K.
Tanila, H.
Miguel-Hidalgo, J. J.
Iqbal, K.
机构：
[1] Forest Res Inst, Dept Pharmacol, Jersey City, NJ USA
[2] Forest Res Inst, Dept Toxicol, Jersey City, NJ USA
[3] Indiana Univ, Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA
[4] Univ Kuopio, Dept Neurosci, FIN-70211 Kuopio, Finland
[5] Univ Kuopio, Dept Neurol, FIN-70211 Kuopio, Finland
[6] Univ Mississippi, Med Ctr, Dept Psychiat, Jackson, MS 39216 USA
[7] New York State Inst Basic Res Dev Disabil, Dept Neurochem, Staten Isl, NY 10314 USA
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2005年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：187 / 187
页数：1
相关论文
共 50 条
  • [1] Preclinical basis for the efficacy of memantine in Alzheimer's disease
    Banerjee, PK
    Lahiri, DK
    Tanila, H
    Miguel-Hidalgo, JJ
    Iqbal, K
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S572 - S572
  • [2] Preclinical basis for the efficacy of memantine in Alzheimer's disease
    Banerjee, PK
    Lahiri, DK
    Tanila, H
    Miguel-Hidalgo, JJ
    Iqbal, K
    BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 173S - 174S
  • [3] Preclinical basis for memantine efficacy in Alzheimer's disease
    Danysz, W.
    Wenk, G. L.
    Banerjee, P.
    Parsons, C. G.
    BEHAVIOURAL PHARMACOLOGY, 2006, 17 (5-6): : 538 - 538
  • [4] Preclinical basis for the efficacy of memantine in Alzheimer's disease
    Banerjee, P
    Lahiri, D
    Tanila, H
    Miguel-Hidalgo, JJ
    Iobal, K
    INTERNATIONAL PSYCHOGERIATRICS, 2005, 17 : 208 - 208
  • [5] Efficacy of memantine in the treatment of Alzheimer's disease
    Guix, JLM
    Plarrumaní, AL
    NEUROLOGIA, 2005, 20 (10): : 686 - 691
  • [6] Efficacy of memantine in moderate to severe Alzheimer's disease
    Wilkinson, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 318 - 318
  • [7] The efficacy and safety of memantine for the treatment of Alzheimer's disease
    Matsunaga, Shinji
    Kishi, Taro
    Nomura, Ikuo
    Sakuma, Kenji
    Okuya, Makoto
    Ikuta, Toshikazu
    Iwata, Nakao
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (10) : 1053 - 1061
  • [8] Memantine Multiple Mechanisms of Action in Preclinical Models of Alzheimer's Disease
    Banerjee, Pradeep K.
    NEUROLOGY, 2011, 76 (09) : A228 - A228
  • [9] Memantine Multiple Mechanisms of Action in Preclinical Models of Alzheimer's Disease
    Banerjee, Pradeep K.
    BIOLOGICAL PSYCHIATRY, 2011, 69 (09) : 27S - 27S
  • [10] The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease
    Rogawski, MA
    Wenk, GL
    CNS DRUG REVIEWS, 2003, 9 (03): : 275 - 308
12345